Covid jabs to key workers, then elderly followed by comorbid people of 24-60 yrs hikes impact: ICMR study
According to the study, the priority groups together account for about 18 per cent of India s population.
Share Via Email
| A+A A- By PTI
NEW DELHI: In high-transmission settings, vaccinating key workers, including healthcare professionals, first, followed by those above 60 years and then comorbid individuals aged 24 to 60 years will have a greater impact in reducing COVID-19 morbidity and mortality, according to a mathematical model-based analysis.
Highlighting the findings of the study, the Indian Council of Medical Research (ICMR) said in low-intensity transmission areas such as sparsely populated areas, vaccinating individuals with comorbidity after key workers and then reaching out to those above 60 years appears to be an elegant public health approach.
the death rate had increased significantly in the second wave of covid 19 in india, says study
भारत में कोरोना की दूसरी लहर में मृत्यु दर काफी बढ़ गई थी, अध्ययन में हुआ खुलासा
Edited by
Subscribe
Covid Death Toll in Second Wave: अध्ययन में कहा गया है कि अस्पताल में भर्ती और पुष्ट कोविड-19 रोगियों के जनसांख्यिकीय, नैदानिक उपचार और परिणाम आंकड़ों को पूरे भारत के 41 अस्पतालों के इलेक्ट्रॉनिक डेटा पोर्टल में डाला गया था।
भारत में कोरोना की दूसरी लहर में मृत्यु दर काफी बढ
NEW DELHI: “Smart vaccination” approaches that target the vulnerable population in the context of the Indian Covid-19 epidemic make for a smarter public health choice than mass vaccination, a mathematical modelling-based analysis by the Indian Council of Medical Research (ICMR) published in the British Medical Journal (BMJ) says.
The analysis shows an infection-preventing vaccine with 60% efficacy covering all priority groups would reduce peak symptomatic incidence of Covid-19 by 20.6% and total deaths by 29.7%. A similar vaccine with ability to prevent symptoms, but not infection, will reduce peak incidence of symptomatic cases by 10.4% and cumulative mortality by 32.9%.
The study supports a focus on vulnerable or priority group vaccination that seeks to reduce the incidence of mortality and offer greater protection against the disease. In a situation when vaccine supply is insufficient to cover all priority groups, model projections suggest that after key workers, prior
Hospitalised Covid-19 patients were more likely to need oxygen and ventilation and had a significantly greater risk of dying during India’s second wave than the first, a nationwide analysis from 44 hospitals has found.
The analysis, released on Saturday by a consortium of doctors and medical researchers, has found that mortality among sampled patients during the second wave was 13.3 per cent, or 30 per cent higher than the 10.2 per cent mortality observed during the first wave.
Advertisement
The findings are similar to those released earlier this week by doctors from nine Max hospitals in five northern states that had found a 40 per cent increase in mortality during the second wave.
SC dismisses doctor s plea seeking trials of his Ayurveda-based medicine for treating Covid-19
The Supreme Court on Saturday dismissed a plea filed by a doctor seeking trial of his Ayurveda-based medicine which he claimed to have developed for treatment of Covid-19.
advertisement
UPDATED: July 4, 2021 04:16 IST
The SC dismissed the petition and said it is not in a position to assess the petitioner s claim regarding the efficacy of his Ayurveda-based remedy. (Photo: PTI file)
The Supreme Court has dismissed a plea filed by a doctor seeking directions to the Centre and the Ministry of Ayush to conduct trials of a medicine which he claims to have developed for treatment of Covid-19.